[HTML][HTML] The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease

C Clark, M Rabl, L Dayon, J Popp - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …

[HTML][HTML] The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease

C Clark, M Rabl, L Dayon, J Popp - Frontiers in Aging …, 2022 - ncbi.nlm.nih.gov
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …

The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease

C Clark, M Rabl, L Dayon… - Frontiers in aging …, 2022 - pubmed.ncbi.nlm.nih.gov
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …

The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease.

C Clark, M Rabl, L Dayon, J Popp - Frontiers in Aging Neuroscience, 2022 - europepmc.org
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …

The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease

C Clark, M Rabl, L Dayon, J Popp - Frontiers In Aging …, 2022 - infoscience.epfl.ch
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …

The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease.

C Clark, M Rabl, L Dayon… - Frontiers in Aging …, 2022 - search.ebscohost.com
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …

The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease

C Clark, M Rabl, L Dayon, J Popp - Frontiers in Aging Neuroscience, 2022 - zora.uzh.ch
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …

The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease.

C Clark, M Rabl, L Dayon, J Popp - Frontiers in Aging Neuroscience, 2022 - europepmc.org
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …